Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: Br J Haematol. 2018 Jan 23;184(3):450–455. doi: 10.1111/bjh.15099

Table I.

EZH2 mutation description

Case Subtype Monosomy 7 or del(7q) IHC Score EZH2 mutation Missense/Nonsense Previously reported Clinical significance
1 AML-MRC Yes 0 c.1555 + 1G>T Missense Yes Yes, Significant
2 Other No 0·75 c.2187_2188insT; p.D730 fs Missense Yes Yes, Significant
3 Other No 0·15 c.862C>T; c.1852_6C>T and c.2007C>A; p. S669R Yes Yes, Significant
4 MDS/MPN No 2·125 c.2196_2A>T Yes Yes, Significant
5 AML-MRC No 0 c.1505G>A; R502Q and c.1694G>C; C565S Missense Yes Yes, Significant
6 Other No 0·6 c.71T>C; p.M24T Missense Yes Yes, Significant
7 AML-MRC No 1·5 p.A656V Missense Yes Yes, Significant
8 AML-MRC Yes 1·25 c.2080C>T; p.H694Y Missense Yes Yes, Significant
9 MDS/MPN Yes 0·1 c.1673delG No Yes, Significant
10 Other No 0·875 c.490G>A; p. G164R,c.492delG and c.2187delT No Yes, Significant
11 MDS-EB-I No 2·125 p.R690H Missense Yes Yes, Significant
12 MDS/MPN No 1·5 p.R690H Missense Yes Yes, Significant
13 Other No 0·525 p.A685T (c.2053G>A) and p.K571E (c.1711A>G) Missense Yes Yes, Significant
14 MDS/MPN No 1·05 p.R690H Missense Yes Yes, Significant
15 Other Yes 0·8 c.2139A>G; pl713M Missense Yes Probably Significant
16 MDS/MPN No 0·15 p.D185H Missense Yes Probably Significant
17 Other No 2 D432EFS, Y741H Missense No Probably Significant
18 AML-MRC No 1·625 p.G663R (c.1987G>A); g.148507476C>T Yes Probably Significant
19 AML-MRC Yes 0·27 c.923C>G; p.P308R Missense No Probably Significant
20 Other No 0·3 p.D185H 0 Yes Probably Significant
21 Other No 0·1125 2111-2A>G Nonsense Yes Probably Significant
22 AML-MRC No 0·75 p.D185H Missense Yes Probably Significant
23 MDS-EB-II No 1 p.D185H Missense Yes Probably Significant
24 Other No 1 p.D185H Missense Yes Probably Significant
25 MDS-EB-I No 0·9 p.D185H Missense Yes Probably Significant
26 Other No 0·15 p.D185H (c.553G>C) Missense Yes Probably Significant
27 Other No 0·06 p.Q55* (c.163C>T), Nonsense No Probably Significant
28 MDS/MPN No 0·675 p.N699H c.2095A>C and p.R684C c.2050C>T Missense Yes Probably Significant
29 MDS/MPN No 1·4 p.Q273* Missense Yes Probably Significant
30 CMML No 0·15 p.R313Q Missense Yes Probably Significant
31 MDS/MPN No 0·15 p.R690H and chr7:g148598715A>T Missense Yes Probably Significant
32 Other No 0·3 c.1852_6C>T Yes Probably not significant
33 MDS/MPN No 0·45 c.2110G>T; V704F Missense No Unknown
34 Other No 1·5 D730FS Yes Unknown
35 AML-MRC No 0·075 c.1160_1163del (p.D387Vfs*39) Missense No Unknown
36 Other No 0·625 p.D185H (c.553G>C) Missense Yes Unknown
37 MDS/MPN No 0 p.Y153* c.459T>A No Unknown
38 MDS-EB-I Yes 0·05 c.1547·3C>G Unknown
39 MDS-EB-II Yes 0·7 R882H Unknown
40 Other No 0·8 c.2097C>G, p.N699K Nonsense No Unknown
41 Other Yes 0·15 p.R33Afs*12 (c.96_97insG), Missense No Unknown
42 MDS-EB-II No 0·1 c.1643G>T; C548F Missense Yes Unknown
43 MDS/MPN No 0·0125 IVS1410 + 2T>A No Unknown
44 Other No 0·225 c.485·1G>C; and c.1957C>A; Q653K No Unknown
45 MDS/MPN No 1·625 c.2050C>T; R684C Missense Yes Unknown
46 MDS-EB-II Yes 0·00525 p.D193H No Unknown
47 Other No 0 chr7:g.148511050C>T Yes Unknown
48 Other No 0·975 p.Q648E and p.R502Q Missense Yes Unknown
49 MDS/MPN No 0·01 p.Y677H and p.F627L Missense No Unknown
50 Other Yes 0·3 p.D176H Missense Yes Unknown
51 Other No 0·03 c.293_294insT Missense Yes Unknown
52 AML-MRC Yes 0·1875 p.R207 Nonsense Yes Unknown
53 AML-MRC No 1·35 p.V674M and p.C443Y Missense Yes Unknown
54 MDS/MPN Yes 0·1 p.T283R Missense No Unknown
55 MDS/MPN No 0 c.1663del(p.C555Vfs* 123) No Unknown
56 MDS-EB-I No 0·0875 p.I646T (c.1937T>C), Missense Yes Unknown
57 Other No 0·6 p.T283M and p.V662Cfs*13 Missense Yes Unknown
58 MDS/MPN No 0·3 p.Y663C No Unknown
59 MDS/MPN No 0·8 p.S669G No Unknown
60 MDS-EB-I No 2·25 p.A702P No Unknown
61 MDS-EB-I No 0·015 p.R360Tfs*5 No Unknown

AML-MRC, acute myeloid leukemia with myelodysplasia-related changes

CMML, chronic myelomonocytic leukaemia; IHC, immunohistochemistry; MDS-EB-I/II, myelodysplastic syndrome with excess blasts type I/II; MDS, myelodysplastic syndromes; MPN, myeloproliferative neoplasm; Other: MDS unclassifiable (MDS-U), MDS with multilineage dysplasia (MDS-MLD), MDS with ring sideroblasts and multilineage dysplasia (MDS-RS-MLD), MDS with single lineage dysplasia (MDS-SLD), MDS with ring sideroblasts and single lineage dysplasia (MDS-RS-SLD), therapy-related MDS (tMDS).